ClinConnect ClinConnect Logo
Search / Trial NCT04939012

Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women with Substance Use Disorder in the Immediate Postpartum Period

Launched by UNIVERSITY OF PITTSBURGH · Jun 23, 2021

Trial Information

Current as of July 21, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring a new tool called MyPath, designed to help women with substance use disorders make important decisions about birth control after giving birth. The study aims to understand how this supportive tool can improve the choices women make about their reproductive health during the early postpartum period, which is the time right after having a baby.

To be eligible for this trial, participants must be at least 18 years old and either pregnant between 22 to 37 weeks or within 9 days after giving birth. They also need to have a diagnosis of a substance use disorder, such as issues related to opioids or stimulants. Participants can expect to receive guidance and support through the MyPath tool, helping them navigate their options for contraception and reproductive planning. The study is currently recruiting participants, and it’s important to note that those with certain medical or social issues, such as a recent fetal death or being incarcerated, may not be able to participate.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria
  • Prenatal Cohort:
  • Be greater than or equal to 18 years of age.
  • Be pregnant with an EGA of 22 to 37 weeks at enrollment.
  • Plan to deliver at MWH.
  • Meet DSM-5 criteria for a SUD (i.e., opioid, stimulant or other use disorder) and/or have a diagnosis code for a substance use disorder in their medical record.
  • Postpartum Cohort:
  • Be greater than or equal to 18 years of age.
  • Be 0-9 days postpartum at enrollment.
  • Have delivered at MWH.
  • Meet DSM-5 criteria for a SUD (i.e., opioid, stimulant or other use disorder) and/or have a diagnosis code for a substance use disorder in their medical record.
  • Exclusion Criteria:
  • Have had a fetal or neonatal death with their current pregnancy.
  • Be currently in jail or prison as required by court of law. Persons on probation or in residential facilities do not need to be excluded.
  • Have any other condition (social or medical) which, in the opinion of the Investigator, would make study participation unsafe, make study participation difficult, and/or complicate data interpretation.

About University Of Pittsburgh

The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.

Locations

Pittsburgh, Pennsylvania, United States

Patients applied

0 patients applied

Trial Officials

Elizabeth Krans, MD

Principal Investigator

University of Pittsburgh

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials